InnovHeart Srl.
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its novel TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve. Saturn is a low-profile prosthetic designed for both Trans-apical and Trans-septal delivery. InnovHeart was founded in 2015 by Giovanni Righini, CTO & Board Member, with the support of Genextra S.p.A.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Medical Equipment
- Market Focus:
- Internationally (various countries)
About Us
Our company has adopted an Organizational, Management and Control Model in compliance with the Italian Legislative Decree n. 231/2001 and subsequent additions.
The Model includes:
- a General section (Italian version, English-summary)
- our Code of Ethics (Italian, English)
InnovHeart’s Quality Management System is ISO 13485:2016 certified. The full certificate is available in English and in Italian.
Mission
Our company mission is to bring patients a novel therapeutic system suitable to replace incompetent Mitral Valves based on a safe, effective, and easy-to-use transcatheter technology. InnovHeart is committed to pursuing this goal with the highest level of quality.